Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.
Oude Egbrink, M., & IJzerman, M. J. (2014). The value of quantitative patient preferences in regulatory benefit-risk assessment. Journal of market access & health policy, 2(22761), -. . https://doi.org/10.3402/jmahp.v2.22761